DrugPatentWatch Database Preview
Drugs in Development Information for NRX-1074
» See Plans and Pricing
What is the development status for investigational drug NRX-1074?
NRX-1074 is an investigational drug.
There have been 13 clinical trials for NRX-1074.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2018.
The most common disease conditions in clinical trials are Depressive Disorder, Depression, and Bipolar Disorder. The leading clinical trial sponsors are Naurex, Inc, NeuroRx, Inc., and Target Health Inc.
There is one US patent protecting this investigational drug and thirty-nine international patents.
Summary for NRX-1074
| US Patents | 1 |
| International Patents | 39 |
| US Patent Applications | 5 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2018-05-01) |
| Vendors | 5 |
Recent Clinical Trials for NRX-1074
| Title | Sponsor | Phase |
|---|---|---|
| NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression | Bracket, Inc. | Phase 3 |
| NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression | Stats Collaborative | Phase 3 |
| NRX100 vs. Placebo for Rapid Stabilization of Acute Suicidal Ideation and Behavior in Bipolar Depression | Target Health Inc. | Phase 3 |
Clinical Trial Summary for NRX-1074
Top disease conditions for NRX-1074
Top clinical trial sponsors for NRX-1074
US Patents for NRX-1074
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| NRX-1074 | Start Trial | NMDA receptors modulators and uses thereof | Northwestern University (Evanston, IL) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for NRX-1074
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| NRX-1074 | Australia | 2011215704 | 2030-02-11 | Start Trial |
| NRX-1074 | Australia | 2012328927 | 2030-02-11 | Start Trial |
| NRX-1074 | Australia | 2017213587 | 2030-02-11 | Start Trial |
| NRX-1074 | Australia | 2019204073 | 2030-02-11 | Start Trial |
| NRX-1074 | Brazil | 112014009851 | 2030-02-11 | Start Trial |
| NRX-1074 | Canada | 2789331 | 2030-02-11 | Start Trial |
| NRX-1074 | Canada | 2853364 | 2030-02-11 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
